Picard Medical (PMI) Proxy Filing summary

Executive summary

• Special meeting scheduled for October 10, 2025, to be held virtually for all stockholders of record as of September 16, 2025.

• Main purpose is to approve an amendment to the 2021 Equity Incentive Plan, increasing available shares to 18,000,000 and including warrants as an award type.

• The Board unanimously recommends voting in favor of the amendment.

• Proxy materials were mailed on or about September 29, 2025, and voting can be done online, by phone, or by mail.

Voting matters and shareholder proposals

• Proposal seeks to amend the 2021 Equity Incentive Plan to increase share reserve and add warrants as awards.

• Board recommends a vote FOR the proposal.

• Only stockholders of record as of September 16, 2025, are eligible to vote; each share has one vote.

• Abstentions count as votes against; broker non-votes have no effect.

• Final voting results will be published in a Form 8-K within four business days after the meeting.

Board of directors and corporate governance

• The Board and its Compensation Committee oversee the administration of the Equity Incentive Plan.

• The Board has authority to amend, suspend, or terminate the plan, subject to stockholder approval for certain changes.